Genetic testing has, however, limited sensitivity, as > 25% of patients with a clinical diagnosis of FHH do not harbor germline CASR/GNA11/AP2S1 genetic variation. The gene discussed is CASR; the disease is familial hypocalciuric hypercalcemia.